1. Long‐Term Safety ofIn UteroExposure to Anti‐TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. (March 2018) Authors: Chaparro, M; Verreth, A; Lobaton, T; Gravito‐Soares, E; Julsgaard, M; Savarino, E; Magro, F; Biron, Avni I; Lopez‐Serrano, P; Casanova, M J; Gompertz, M; Vitor, S; Arroyo, M; Pugliese, D; Zabana, Y; Vicente, R; Aguas, M; Shitrit, Bar‐Gil A; Gutierrez, A; Doherty, G A Journal: American journal of gastroenterology Issue: Volume 113:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P739 The progression of inflammatory bowel disease throughout Latin America: a systematic review. (25th January 2019) Authors: Kotze, P; Underwood, F; Damiao, A; Ferraz, J; Saad-Hossne, R; Toro, M; Iade, B; Bosques-Padilla, F; Teixeira, F; Juliao-Baños, F; Simian, D; Ghosh, S; Panaccione, R; Kaplan, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗